Journal ArticleOPEN ACCESS

Off-the-shelf TCR for graft-versus-leukemia without GVHD

Blood (2018) 131(1) 5-7
DOI: 10.1182/blood-2017-11-812990
0Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Dossa et al report the engineering of T-cell receptor (TCR) transgenic T cells against the human minor histocompatibility antigen HA-1 for the prevention or treatment of leukemia relapse after allogeneic stem cell transplantation.

Cite

CITATION STYLE

APA

Locke, F. L., & Anasetti, C. (2018). Off-the-shelf TCR for graft-versus-leukemia without GVHD. Blood, 131(1), 5–7. https://doi.org/10.1182/blood-2017-11-812990

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free